US Patent 9273057 Imidazotriazinecarbonitriles useful as kinase inhibitors
Patent 9273057 was granted and assigned to Bristol-Myers Squibb on March, 2016 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
July 12, 2013
Date of Patent
March 1, 2016
Patent Applicant
Patent Application Number
14414152
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 9273057 Imidazotriazinecarbonitriles useful as kinase inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
